Literature DB >> 8890256

Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line.

M Heinemann1, M Susa, U Simnacher, R Marre, A Essig.   

Abstract

Chlamydia pneumoniae was able to survive and to multiply in the human monocytic cell line Mono Mac 6. Growth of C. pneumoniae induced production of tumor necrosis factor alpha, interleukin 1beta, and interleukin 6, as well as up-regulation of the CD14 molecule in a time-dependent manner. Infection of monocytic cells and a proinflammatory cytokine response may be important in C. pneumoniae pathogenesis.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8890256      PMCID： PMC174462          DOI： 10.1128/iai.64.11.4872-4875.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  25 in total

1.  Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6.

Authors:  D M Magee; J G Smith; C A Bleicker; C J Carter; L F Bonewald; J Schachter; D M Williams
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Synergistic interactions of IL-1 and IL-6 in T cell activation. Mitogen but not antigen receptor-induced proliferation of a cloned T helper cell line is enhanced by exogenous IL-6.

Authors:  H Mizutani; L T May; P B Sehgal; T S Kupper
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

3.  Chlamydia trachomatis-induced production of interleukin-1 by human monocytes.

Authors:  C D Rothermel; J Schachter; P Lavrich; E C Lipsitz; T Francus
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

5.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

6.  A model of genital Chlamydia trachomatis infection using human xenografts in severe combined immunodeficiency mice.

Authors:  A Essig; A Rudolphi; M Heinemann; H Rosenthal; R Kaufmann; J Reimann; R Marre
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines.

Authors:  J S Friedland; D G Remick; R Shattock; G E Griffin
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

8.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes.

Authors:  H W Ziegler-Heitbrock; E Thiel; A Fütterer; V Herzog; A Wirtz; G Riethmüller
Journal:  Int J Cancer       Date:  1988-03-15       Impact factor: 7.396

10.  Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-alpha mRNA but not of IL-1 beta mRNA.

Authors:  N Takasuka; T Tokunaga; K S Akagawa
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422
View more
  29 in total

1.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

2.  Synergistic Costimulatory Effect of Chlamydia pneumoniae with Carbon Nanoparticles on NLRP3 Inflammasome-Mediated Interleukin-1β Secretion in Macrophages.

Authors:  Junji Matsuo; Shinji Nakamura; Seiji Takeda; Kasumi Ishida; Tomohiro Yamazaki; Mitsutaka Yoshida; Hitoshi Chiba; Shu-Ping Hui; Hiroyuki Yamaguchi
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

3.  Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Authors:  Luis M Gomez; Lauren Anton; Shindu K Srinivas; Michal A Elovitz; Samuel Parry
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

4.  Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts.

Authors:  Laura Mannonen; Eveliina Markkula; Mirja Puolakkainen
Journal:  Med Microbiol Immunol       Date:  2011-01-30       Impact factor: 3.402

5.  Shear Stress Enhances Chemokine Secretion from Chlamydia pneumoniae-infected Monocytes.

Authors:  Shankar J Evani; Shatha F Dallo; Ashlesh K Murthy; Anand K Ramasubramanian
Journal:  Cell Mol Bioeng       Date:  2013-09-01       Impact factor: 2.321

6.  Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation.

Authors:  A Essig; U Simnacher; M Susa; R Marre
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity.

Authors:  C Wahl; F Oswald; U Simnacher; S Weiss; R Marre; A Essig
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts.

Authors:  Jürgen Baumert; Karl-Hermann Schmidt; Annett Eitner; Eberhard Straube; Jürgen Rödel
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

Review 9.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

10.  cIAP-1 controls innate immunity to C. pneumoniae pulmonary infection.

Authors:  Hridayesh Prakash; Daniel Becker; Linda Böhme; Lori Albert; Martin Witzenrath; Simone Rosseau; Thomas F Meyer; Thomas Rudel
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.